Agenus reported $22.46M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agenus AGEN:US USD 22.46M 3.56M
Amgen AMGN:US USD 5.06B 20M
AstraZeneca AZN:LN USD 8.86B 3M
Bristol Myers Squibb BMY:US USD 8.86B 345M
CSL CSL:AU USD 2.28B 1.16B
Eli Lilly And LLY:US USD 5.36B 305M
Gilead Sciences GILD:US USD 5.65B 829M
GlaxoSmithKline GSK:LN GBP 5.44B 650M
Glaxosmithkline GSK:US GBP 5.44B 650M
Intrexon XON:US USD 15.14M 14.04M
Jiangsu Hengrui Me. 600276:CH CNY 4.69B 811.31M
Johnson & Johnson JNJ:US USD 15.94B 56M
Karyopharm Therapeutics KPTI:US USD 35.16M 3.58M
MacroGenics MGNX:US USD 38.59M 14.99M
Merck MRK:GR EUR 3.66B 200M
Merk MRK:US USD 11.52B 1.08B
Novartis NOVN:VX USD 9.18B 151M
Pfizer PFE:US USD 16.55B 2.52B
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Veracyte VCYT:US USD 49.58M 1.75M
YTE INCY:US USD 774.02M 92.14M